Position in PFE
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$127,377,422
+$62,879,575 QoQ
Shares Held
4,536,233
+75.1% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026FIFTH THIRD BANCORP holds $3,423,078,141 across 17 Drug Manufacturers - General names. PFE ranks #6 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,963,490 | $1,805,959,197 | |
| 2 | JNJ |
Johnson & Johnson
|
1,969,767 | $481,489,845 | |
| 3 | ABBV |
AbbVie Inc.
|
2,197,894 | $478,019,966 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,543,397 | $185,655,225 | |
| 5 | AMGN |
Amgen Inc
|
461,207 | $162,275,682 | |
| 6 | PFE |
Pfizer Inc
This page
|
4,536,233 | $127,377,422 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
668,661 | $93,191,283 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,191,379 | $72,257,136 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $127,377,422 | 4,536,233 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $64,497,847 | 2,590,275 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $65,914,925 | 2,586,928 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $64,976,362 | 2,680,543 | Shares | Defined | 2025-07-15 | |
| 2025-03-31 | $70,397,383 | 2,778,113 | Shares | Defined | 2025-04-15 | |
| 2024-12-31 | $69,697,122 | 2,627,106 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $80,624,987 | 2,785,936 | Shares | Defined | 2024-10-17 | |
| 2024-06-30 | $73,194,001 | 2,615,940 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $66,890,542 | 2,410,470 | Shares | Defined | 2024-04-23 | |
| 2023-12-31 | $70,534,377 | 2,449,961 | Shares | Defined | 2024-01-19 | |
| 2023-09-30 | $88,077,760 | 2,655,344 | Shares | Defined | 2023-10-31 | |
| 2023-06-30 | $100,319,139 | 2,734,982 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $122,147,407 | 2,993,809 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $157,734,244 | 3,078,342 | Shares | Defined | 2023-01-25 | |
| 2022-09-30 | $133,197,825 | 3,043,826 | Shares | Defined | 2022-10-25 | |
| 2022-06-30 | $159,914,016 | 3,050,048 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $159,170,644 | 3,074,573 | Shares | Defined | 2022-04-19 | |
| 2021-12-31 | $174,652,066 | 2,957,698 | Shares | Defined | 2022-02-01 | |
| 2021-09-30 | $120,625,286 | 2,804,587 | Shares | Defined | 2021-10-15 | |
| 2021-06-30 | $104,732,401 | 2,674,474 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $97,844,187 | 2,700,640 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $102,085,209 | 2,773,301 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $102,838,106 | 2,802,131 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $86,294,146 | 2,638,962 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $85,295,450 | 2,613,222 | Shares | Defined | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||